- Home
- VYGR vs MERC Comparison
VYGR vs MERC Comparison
Compare VYGR & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- MERC
- Stock Information
- Founded
- VYGR 2013
- MERC 1968
- Country
- VYGR United States
- MERC Canada
- Employees
- VYGR N/A
- MERC N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- VYGR Health Care
- MERC Basic Materials
- Exchange
- VYGR Nasdaq
- MERC Nasdaq
- Market Cap
- VYGR 231.9M
- MERC 190.9M
- IPO Year
- VYGR 2015
- MERC 1987
- Fundamental
- Price
- VYGR $4.23
- MERC $1.80
- Analyst Decision
- VYGR Strong Buy
- MERC Hold
- Analyst Count
- VYGR 7
- MERC 2
- Target Price
- VYGR $17.00
- MERC $3.50
- AVG Volume (30 Days)
- VYGR 551.0K
- MERC 617.4K
- Earning Date
- VYGR 11-06-2025
- MERC 11-06-2025
- Dividend Yield
- VYGR N/A
- MERC 12.23%
- EPS Growth
- VYGR N/A
- MERC N/A
- EPS
- VYGR N/A
- MERC N/A
- Revenue
- VYGR $42,580,000.00
- MERC $1,906,971,000.00
- Revenue This Year
- VYGR N/A
- MERC N/A
- Revenue Next Year
- VYGR $107.10
- MERC $13.33
- P/E Ratio
- VYGR N/A
- MERC N/A
- Revenue Growth
- VYGR N/A
- MERC N/A
- 52 Week Low
- VYGR $2.65
- MERC $1.55
- 52 Week High
- VYGR $7.44
- MERC $8.28
- Technical
- Relative Strength Index (RSI)
- VYGR 41.58
- MERC 26.03
- Support Level
- VYGR $4.10
- MERC $1.89
- Resistance Level
- VYGR $4.30
- MERC $1.97
- Average True Range (ATR)
- VYGR 0.26
- MERC 0.16
- MACD
- VYGR -0.10
- MERC -0.04
- Stochastic Oscillator
- VYGR 20.89
- MERC 28.21
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.